Macrophage migration inhibitory factor ( MIF ) promotes intervertebral disc degeneration through the NF‐κB pathway, and the MIF inhibitor CPSI ‐1306 alleviates intervertebral disc degeneration in a mouse model
The FASEB Journal · 2023
DOI: 10.1096/fj.202301441r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2023. Verfasst von Yejin Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Lishui Central Hospital and Fifth Affiliated Hospital of Wenzhou Medical College, Lishui, China. Hauptthemen laut MEDLINE: Intervertebral Disc Degeneration, Macrophage Migration-Inhibitory Factors, Nucleus Pulposus, Intervertebral Disc. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Lishui Key Research and Development program, Zhejiang Key Research and Development program.
Abstract (Originalsprache)
Lumbar intervertebral disc degeneration(IDD) is a prevalent inflammatory disease caused by many proinflammatory factors, such as TNF and IL‐1β. Migration inhibitory factor (MIF) is an upstream inflammatory factor widely expressed in vivo that is associated with a variety of inflammatory diseases or malignant tumors and has potential therapeutic value in many diseases. We explored the role of MIF in intervertebral disc degeneration by regulating the content of exogenous MIF or the expression of MIF in cells. Upon inducing degeneration of nucleus pulposus (NP) cells with IL‐1β, we found that the increase in intracellular and exogenous MIF promoted the catabolism induced by proinflammatory factors in NP cells, while silencing of the MIF gene alleviated the degeneration to some extent. In a mouse model, the intervertebral disc degeneration of MIF‐KO mice was significantly less than that of wild‐type mice. To explore the treatment of intervertebral disc degeneration, we selected the small‐molecular MIF inhibitor CPSI‐1306. CPSI‐1306 had a therapeutic effect on intervertebral disc degeneration in the mouse model. In summary, we believe that MIF plays an important role in intervertebral disc degeneration and is a potential therapeutic target for the treatment of intervertebral disc degeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Lishui Central Hospital and Fifth Affiliated Hospital of Wenzhou Medical College, Lishui, China.
- Department of Orthopaedics, The Second Affiliated Hospital of Wenzhou Medical College, Wenzhou, China.
- Department of Orthopaedics, The First People's Hospital of Fuyang, Hangzhou, China.
ORCID-Profile: Yejin Zhang, Hehuan Lai, Dengwei He
Förderung
- Lishui Key Research and Development program
- Zhejiang Key Research and Development program
Zitieren
APA
Zhang, Y., Zheng, L., Fang, J., Ni, K., Hu, X., Ye, L., Lai, H., Yang, T., Chen, Z., & He, D. (2023). Macrophage migration inhibitory factor ( MIF ) promotes intervertebral disc degeneration through the NF‐κB pathway, and the MIF inhibitor CPSI ‐1306 alleviates intervertebral disc degeneration in a mouse model. The FASEB Journal. https://doi.org/10.1096/fj.202301441r
Vancouver
Zhang Y, Zheng L, Fang J, Ni K, Hu X, Ye L, et al. Macrophage migration inhibitory factor ( MIF ) promotes intervertebral disc degeneration through the NF‐κB pathway, and the MIF inhibitor CPSI ‐1306 alleviates intervertebral disc degeneration in a mouse model. The FASEB Journal. 2023. doi:10.1096/fj.202301441r
BibTeX
@article{Zhang2023,
author = {Zhang, Yejin and Zheng, Lin and Fang, Jiawei and Ni, Kainan and Hu, Xingyu and Ye, Lin and Lai, Hehuan and Yang, Tao and Chen, Zhenzhong and He, Dengwei},
title = {Macrophage migration inhibitory factor ( MIF ) promotes intervertebral disc degeneration through the NF‐κB pathway, and the MIF inhibitor CPSI ‐1306 alleviates intervertebral disc degeneration in a mouse model},
journal = {The FASEB Journal},
year = {2023},
doi = {10.1096/fj.202301441r}
}
EUVIMED